Vitamin Deficiency Treatment Market

Vitamin Deficiency Treatment Market (Product Type: Vitamin B Complex Supplements, Vitamin C, Vitamin A , Vitamin D, Vitamin E, and Vitamin K; Route of Administration: Oral and Parenteral; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2028

Growing Prevalence of Vitamin Deficiency Cases Worldwide to Propel Market Growth

The healthcare sector is continually finding new ways to address the burdening problems associated with vitamin deficiencies. As the number of individuals suffering from vitamin deficiencies continues to grow at an exponential rate worldwide, vitamin deficiency treatments have gained a great amount of attention over the past couple of decades. Some of the major factors that are expected to influence the expansion of the vitamin deficiency treatment market during the forecast period include rising prevalence of acute and chronic disorders, surge in the number of research & development activities, and growing demand for vitamin D and vitamin B complex, owing to the health benefits.

At present, a great number of research activities are focusing on addressing health issues and risks involved with nutritional deficiencies. Vitamin D testing and treatment has witnessed considerable growth in the past few years. Guidelines pertaining to the treatment of various vitamin deficiencies continue to evolve due to research. As vitamin D deficiency continues to emerge as a global burden, apart from vitamin deficiency treatment, tackling vitamin D deficiency would require robust public health actions, including vitamin D food fortification. At the back of these factors, the global vitamin deficiency treatment market is expected to reach a value of ~US$ 9.5 Bn by the end of 2027.

vitamin deficiency treatment market infographic

Notable Progress to Address Vitamin B12 and Vitamin D Deficiencies

Vitamin deficiencies continue to pose a major threat to the overall wellbeing of the society worldwide. Vitamin deficiencies can lead to irritability, nausea, constipation, depression, mental confusion, and muscle weakness, among others. Vitamin B12 deficiencies have increasingly been detected among athletes, individuals with high alcohol consumption, and women who consistently use birth control pills. In the current scenario, the demand for vitamin deficiency treatment is on the rise to address and predominantly incorporate a blend of vitamin B6 with synergistic B vitamins. For several decades, within clinical practices worldwide, vitamin B12 deficiencies often received a blind eye or were misdiagnosed. However, at present, trends suggest that detection, diagnosis, and vitamin deficiency treatment continue to progress at an impressive pace. Diagnosis based on low serum B12 levels and elevated biomarkers including methylmalonic acid and homocysteine continue to make headlines within the vitamin deficiency treatment market. In the current scenario, researchers are also investigating the potential benefits of deploying oral supplementation to combat the symptoms of vitamin B12 deficiency as an alternative to parental treatment.

Over the past decade and during the forecast period, researchers are increasingly exploring the potential solutions to address muscle weakness among the elderly population caused by vitamin D deficiency. The prevalence of vitamin D deficiency has witnessed unprecedented growth over the past few years, due to which the demand for supplementation of 800 IU of vitamin D is required. In most cases, vitamin D is predominantly administered in the form of cholecalciferol. The demand for cholecalciferol is expected to grow in the coming years, as it is considered to be safe for elderly people. The demand for vitamin B complex supplements is projected to remain the highest among all other types of products followed by vitamin C and vitamin D supplements.

Companies Likely to Focus on Research & Development Activities to Gain Advantage

Participants operating in the current vitamin deficiency treatment market are expected to focus on research and development activities to discover new and improved vitamin deficiency treatments. Several companies are also anticipated to eye opportunities in foreign markets, while simultaneously improving their market share in the domestic market. Product launches and expanding the product portfolio are also projected to remain some of the key strategies deployed by market players. For instance, in 2016, Abbott Laboratories expanded its product portfolio by launching two infant nutrition products, including Similac Pro-Advance and Pro-Sensitive. Several companies are also leaning toward inorganic growth strategies such as mergers & acquisitions to improve their market share and brand presence. For instance, Pfizer, Inc. acquired Emergen C in 2012, at the back of which, the sales of Pfizer saw remarkable growth.

vitamin deficiency treatment market segmentation

Analysts’ Viewpoint

The global vitamin deficiency treatment market is expected to grow at a CAGR of 6.5% during the forecast period. The market growth can be primarily attributed to a range of factors, including rising prevalence of vitamin D deficiencies among the elderly population, significant development on the research front, growing emphasis on drug development, and rising awareness pertaining to vitamin deficiencies. Companies operating in the vitamin deficiency treatment market landscape should focus on mergers & acquisitions to improve their market share and overall position. Product launches, research, and expansion of the existing product portfolio are some of the other strategies that should be considered to gain ground in the current vitamin deficiency treatment market during the assessment period. 

Vitamin Deficiency Treatment Market: Overview

  • According to Transparency Market Research’s latest market report on the global vitamin deficiency treatment market for the historical period 2018–2019 and forecast period 2020–2028, rise in global geriatric population and high demand for Vitamin D and Vitamin B complex due to numerous health benefits are projected to drive the global vitamin deficiency treatment market
  • According to the report, the global vitamin deficiency treatment market was valued at US$ 5.46 Bn in 2019 and is anticipated to expand at a CAGR of 6.5% from 2020 to 2028

High Demand for Vitamin D and Vitamin B Complex due to Numerous Health Benefits: Key Drivers

  • Vitamin D plays a significant role in absorbing calcium into the bones, thereby aiding in building and maintaining strong bones. Vitamin D also helps maintain normal blood levels of calcium and phosphorus. Role of Vitamin D supplements is not just restricted to preventing or treating rickets, but it is also known to help maintain normal function of the immune system, normal inflammatory response, and normal muscle function.
  • Vitamin D deficiency is quite common, especially in the young working population, as more and more people are leading a sedentary lifestyle and have a desk job. These people do not receive enough sunlight to activate vitamin D formation in the body, which is leading to increase in vitamin D deficiency.
  • These factors are expected to increase the demand for vitamin D supplements and subsequently, drive the global vitamin deficiency treatment market
  • Vitamin B12, also known as methylcobalamin, is a water-soluble vitamin that plays significant role in the production of red blood cells and DNA, as well as proper functioning of the nervous system. B12 deficiency can cause numerous issues including pernicious anemia, megaloblastic anemia, and sub-acute combined degeneration of spinal cord. Vitamin B12 is derived from animal products such as meat, poultry fish, dairy, and is frequently found to be deficient in vegetarians and vegans.
  • Vitamin B complex is a commonly prescribed vitamin supplement due to their high functionality in maintaining normal body metabolism, thus, driving the global vitamin deficiency treatment market

Rise in Global Geriatric Population

  • Rise in global geriatric population is estimated to fuel the demand for vitamins and other dietary supplements at a steep pace during the forecast period. Rise in geriatric population directly affects the demand for vitamins, primarily due to higher susceptibility to various diseases among this population.
  • Most developed countries have high geriatric population. According to the WHO, the geriatric population is expected to rise at a rapid pace in developed countries such as the U.S., the U.K., and Japan
  • Access to various diagnostic and treatment services has improved due to favorable healthcare policies and the advancement in health care facilities in countries such as the U.S., Japan, the U.K., and other countries in Western Europe, which, in turn, has increased life expectancy of the population. Increase in geriatric population is anticipated to propel the vitamin deficiency treatment market during the forecast period.

Lack of Awareness in Developing Countries to Restrain Global Vitamin Deficiency Treatment Market

  • Vitamin deficiency mostly occurs due to lack of proper dietary nutrition in underdeveloped countries
  • However, a significant number of cases of vitamin deficiency is expected to remain undetected, especially in developing countries such as India and China, making vitamin deficiency a highly under-diagnosed disorder. Lack of awareness about such disorders in underdeveloped and developing countries is expected to restrain the global vitamin deficiency treatment market during the forecast period.

Vitamin Deficiency Treatment Market: Competition Landscape

  • This report profiles major players in the global vitamin deficiency treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The vitamin deficiency treatment market is highly fragmented, with the presence of a few large players in international markets and many small players in regional markets
  • Prominent players operating in the global vitamin deficiency treatment market include 
    • Merck & Co., Inc.
    • Nature’s Bounty
    • Sandoz International (Novartis)
    • DSM
    • Lonza

Vitamin Deficiency Treatment Market: Key Developments

  • In December 2018, Pfizer Inc. and GlaxoSmithKline plc entered into an agreement to create a premier global consumer healthcare company with iconic brands. In 2017, the combined business was approximately US$ 12.7 Bn
  • The report on the global vitamin deficiency treatment market discusses individual strategies, followed by company profiles of vitamin deficiency treatment providers. The competition landscape section has been included in the global vitamin deficiency treatment market report to provide readers with a dashboard view of key market players operating in the global vitamin deficiency treatment market.

Vitamin Deficiency Treatment Market - Segmentation

Product Type

Vitamin B Complex Supplements

Vitamin C (Ascorbic Acid)

Vitamin A (Retinoids)

Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

Vitamin E (Tocopherol)

Vitamin K

Route of Administration

Oral

Parenteral

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of vitamin deficiency treatment market?

Vitamin deficiency treatment market is expected to reach a value of ~US$ 9.5 Bn by the end of 2028

What is the anticipated CAGR of the vitamin deficiency treatment market in the forecast period?

Vitamin deficiency treatment market is anticipated to expand at a CAGR of 6.5% from 2020 to 2028

What are the key driving factors for the growth of the vitamin deficiency treatment market?

Vitamin deficiency treatment market is driven by rise in prevalence of several acute and chronic disorders across the world

Which region is expected to project the highest market share in the global vitamin deficiency treatment market?

Asia Pacific accounted for a major share of the global vitamin deficiency treatment market

Who are the key players in the vitamin deficiency treatment market?

Key players in the global vitamin deficiency treatment market include Koninklijke DSM N.V., Nature’s Bounty, Mallinckrodt Pharmaceuticals, and Pfizer, Inc. Mallinckrodt Pharmaceuticals

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Vitamin Deficiency Treatment Market

    4. Market Overview

        4.1. Introduction

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Vitamin Deficiency Treatment Market Analysis and Forecast, 2018–2028

    5. Key Insights

        5.1. Regulatory Scenario, by Region

        5.2. Value Chain Analysis

    6. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Product Type 

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product Type, 2018–2028

            6.3.1. Vitamin B Complex Supplements

            6.3.2. Vitamin C (Ascorbic Acid)

            6.3.3. Vitamin A (Retinoids)

            6.3.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

            6.3.5. Vitamin E (Tocopherol)

            6.3.6. Vitamin K

        6.4. Market Attractiveness, by Product Type 

    7. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Route of Administration 

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Route of Administration, 2018–2028

            7.3.1. Oral

            7.3.2. Parenteral

        7.4. Market Attractiveness, by Route of Administration 

    8. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Distribution Channel 

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Distribution Channel, 2018–2028

            8.3.1. Hospital Pharmacies

            8.3.2. Retail Pharmacies

            8.3.3. Online Pharmacies

        8.4. Market Attractiveness, by Distribution Channel 

    9. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. North America 

            9.2.2. Europe 

            9.2.3. Asia Pacific 

            9.2.4. Latin America 

            9.2.5. Middle East & Africa 

        9.3. Market Attractiveness, by Region

    10. North America Vitamin Deficiency Treatment Market Analysis and Forecast

        10.1. Introduction

        10.2. Market Value Forecast, by Product Type, 2018–2028

            10.2.1. Vitamin B Complex Supplements

            10.2.2. Vitamin C (Ascorbic Acid)

            10.2.3. Vitamin A (Retinoids)

            10.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

            10.2.5. Vitamin E (Tocopherol)

            10.2.6. Vitamin K

        10.3. Market Value Forecast, by Route of Administration, 2018–2028

            10.3.1. Oral

            10.3.2. Parenteral

        10.4. Market Value Forecast, by Distribution Channel, 2018–2028

            10.4.1. Hospital Pharmacies

            10.4.2. Retail Pharmacies

            10.4.3. Online Pharmacies

        10.5. Market Value Forecast, by Country, 2018–2028

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis 

            10.6.1. By Product Type 

            10.6.2. By Route of Administration 

            10.6.3. By Distribution Channel 

            10.6.4. By Country

    11. Europe Vitamin Deficiency Treatment Market Analysis and Forecast

        11.1. Introduction

        11.2. Market Value Forecast, by Product Type, 2018–2028

            11.2.1. Vitamin B Complex Supplements

            11.2.2. Vitamin C (Ascorbic Acid)

            11.2.3. Vitamin A (Retinoids)

            11.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

            11.2.5. Vitamin E (Tocopherol)

            11.2.6. Vitamin K

        11.3. Market Value Forecast, by Route of Administration, 2018–2028

            11.3.1. Oral

            11.3.2. Parenteral

        11.4. Market Value Forecast, by Distribution Channel, 2018–2028

            11.4.1. Hospital Pharmacies

            11.4.2. Retail Pharmacies

            11.4.3. Online Pharmacies

        11.5. Market Value Forecast, by Country/Sub-region, 2018–2028

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis 

            11.6.1. By Product Type 

            11.6.2. By Route of Administration 

            11.6.3. By Distribution Channel 

            11.6.4. By Country/Sub-region

    12. Asia Pacific Vitamin Deficiency Treatment Market Analysis and Forecast

        12.1. Introduction

        12.2. Market Value Forecast, by Product Type, 2018–2028

            12.2.1. Vitamin B Complex Supplements

            12.2.2. Vitamin C (Ascorbic Acid)

            12.2.3. Vitamin A (Retinoids)

            12.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

            12.2.5. Vitamin E (Tocopherol)

            12.2.6. Vitamin K

        12.3. Market Value Forecast, by Route of Administration, 2018–2028

            12.3.1. Oral

            12.3.2. Parenteral

        12.4. Market Value Forecast, by Distribution Channel, 2018–2028

            12.4.1. Hospital Pharmacies

            12.4.2. Retail Pharmacies

            12.4.3. Online Pharmacies

        12.5. Market Value Forecast, by Country/Sub-region, 2018–2028

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis 

            12.6.1. By Product Type 

            12.6.2. By Route of Administration 

            12.6.3. By Distribution Channel 

            12.6.4. By Country/Sub-region

    13. Latin America Vitamin Deficiency Treatment Market Analysis and Forecast

        13.1. Introduction

        13.2. Market Value Forecast, by Product Type, 2018–2028

            13.2.1. Vitamin B Complex Supplements

            13.2.2. Vitamin C (Ascorbic Acid)

            13.2.3. Vitamin A (Retinoids)

            13.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

            13.2.5. Vitamin E (Tocopherol)

            13.2.6. Vitamin K

        13.3. Market Value Forecast, by Route of Administration, 2018–2028

            13.3.1. Oral

            13.3.2. Parenteral

        13.4. Market Value Forecast, by Distribution Channel, 2018–2028

            13.4.1. Hospital Pharmacies

            13.4.2. Retail Pharmacies

            13.4.3. Online Pharmacies

        13.5. Market Value Forecast, by Country/Sub-region, 2018–2028

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis 

            13.6.1. By Product Type 

            13.6.2. By Route of Administration 

            13.6.3. By Distribution Channel 

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Vitamin Deficiency Treatment Market Analysis and Forecast

        14.1. Introduction

        14.2. Market Value Forecast, by Product Type, 2018–2028

            14.2.1. Vitamin B Complex Supplements

            14.2.2. Vitamin C (Ascorbic Acid)

            14.2.3. Vitamin A (Retinoids)

            14.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

            14.2.5. Vitamin E (Tocopherol)

            14.2.6. Vitamin K

        14.3. Market Value Forecast, by Route of Administration, 2018–2028

            14.3.1. Oral

            14.3.2. Parenteral

        14.4. Market Value Forecast, by Distribution Channel, 2018–2028

            14.4.1. Hospital Pharmacies

            14.4.2. Retail Pharmacies

            14.4.3. Online Pharmacies

        14.5. Market Value Forecast, by Country/Sub-region, 2018–2028

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis 

            14.6.1. By Product Type 

            14.6.2. By Route of Administration 

            14.6.3. By Distribution Channel 

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Company Profiles

            15.1.1. Merck & Co., Inc.

                15.1.1.1. Company Overview

                15.1.1.2. Company Financials

                15.1.1.3. Growth Strategies

                15.1.1.4. SWOT Analysis

            15.1.2. Nature’s Bounty

                15.1.2.1. Company Overview

                15.1.2.2. Growth Strategies

                15.1.2.3. SWOT Analysis

            15.1.3. Sun Pharmaceutical Industries Ltd.

                15.1.3.1. Company Overview

                15.1.3.2. Company Financials

                15.1.3.3. Growth Strategies

                15.1.3.4. SWOT Analysis

            15.1.4. Pfizer, Inc.

                15.1.4.1. Company Overview

                15.1.4.2. Company Financials

                15.1.4.3. Growth Strategies

                15.1.4.4. SWOT Analysis

            15.1.5. Novartis AG 

                15.1.5.1. Company Overview

                15.1.5.2. Company Financials

                15.1.5.3. Growth Strategies

                15.1.5.4. SWOT Analysis

            15.1.6. Cipla, Inc.

                15.1.6.1. Company Overview

                15.1.6.2. Company Financials

                15.1.6.3. Growth Strategies

                15.1.6.4. SWOT Analysis

            15.1.7. DSM

                15.1.7.1. Company Overview

                15.1.7.2. Company Financials

                15.1.7.3. Growth Strategies

                15.1.7.4. SWOT Analysis

            15.1.8. BASF SE

                15.1.8.1. Company Overview

                15.1.8.2. Company Financials

                15.1.8.3. Growth Strategies

                15.1.8.4. SWOT Analysis

            15.1.9. Nestle

                15.1.9.1. Company Overview

                15.1.9.2. Company Financials

                15.1.9.3. Growth Strategies

                15.1.9.4. SWOT Analysis

            15.1.10. GlaxoSmithKline plc

                15.1.10.1. Company Overview

                15.1.10.2. Company Financials

                15.1.10.3. Growth Strategies

                15.1.10.4. SWOT Analysis

    List of Tables

    Table 01: Comparison of Regulatory Requirements for Generic Drugs Dossier Submission in the U.S. and Canada

    Table 02: Global Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Product Type, 2018–2028

    Table 03: Global Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028

    Table 04: Global Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028

    Table 05: Global Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2028

    Table 06: North America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Product Type, 2018–2028

    Table 07: North America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028

    Table 08: North America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028

    Table 09: North America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2028

    Table 10: Europe Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Product Type, 2018–2028

    Table 11: Europe Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028

    Table 12: Europe Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028

    Table 13: Europe Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2028

    Table 14: Asia Pacific Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Product Type, 2018–2028

    Table 15: Asia Pacific Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028

    Table 16: Asia Pacific Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028

    Table 17: Asia Pacific Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2028

    Table 18: Latin America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Product Type, 2018–2028

    Table 19: Latin America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028

    Table 20: Latin America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028

    Table 21: Latin America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2028

    Table 22: Middle East & Africa Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Product Type, 2018–2028

    Table 23: Middle East & Africa Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028

    Table 24: Middle East & Africa Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028

    Table 25: Middle East & Africa Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2028

    List of Figures

    Figure 01: Global Vitamin Deficiency Treatment Market Snapshot 

    Figure 02: Global Vitamin Deficiency Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2028

    Figure 03: Global Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, 2018–2028

    Figure 04: Regulatory Approval Process - The U.S.  

    Figure 05: Regulatory Approval Process - Europe 

    Figure 06: Regulatory Approval Process - Japan

    Figure 07: Drug Development

    Figure 08: Global Vitamin Deficiency Treatment Market Value Share Analysis, by Product Type, 2019 and 2028

    Figure 09: Global Vitamin Deficiency Treatment Market Attractiveness Analysis, by Product Type, 2020–2028

    Figure 10: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin B Complex Supplements, 2018–2028

    Figure 11: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin C (Ascorbic Acid), 2018–2028

    Figure 12: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin A (Retinoids), 2018–2028

    Figure 13: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D), 2018–2028

    Figure 14: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin E (Tocopherol), 2018–2028

    Figure 15: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin K, 2018–2028

    Figure 16: Global Vitamin Deficiency Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2028

    Figure 17: Global Vitamin Deficiency Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2028

    Figure 18: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2018–2028

    Figure 19: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenteral, 2018–2028

    Figure 20: Global Vitamin Deficiency Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2028

    Figure 21: Global Vitamin Deficiency Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2028

    Figure 22: Global Vitamin Deficiency Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018–2028

    Figure 23: Global Vitamin Deficiency Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018–2028

    Figure 24: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2018–2028

    Figure 25: Global Vitamin Deficiency Treatment Market Value Share Analysis, by Region, 2019 and 2028

    Figure 26: Global Vitamin Deficiency Treatment Market Attractiveness Analysis, by Region, 2020–2028

    Figure 27: North America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2028

    Figure 28: North America Vitamin Deficiency Treatment Market Value Share, by Product Type, 2019 and 2028

    Figure 29: North America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Product Type, 2020–2028

    Figure 30: North America Vitamin Deficiency Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2028

    Figure 31: North America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2028

    Figure 32: North America Vitamin Deficiency Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2028

    Figure 33: North America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2028

    Figure 34: North America Vitamin Deficiency Treatment Market Value Share Analysis, by Country, 2019 and 2028

    Figure 35: North America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Country, 2020–2028

    Figure 36: Europe Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2028

    Figure 37: Europe Vitamin Deficiency Treatment Market Value Share, by Product Type, 2019 and 2028

    Figure 38: Europe Vitamin Deficiency Treatment Market Attractiveness Analysis, by Product Type, 2020–2028

    Figure 39: Europe Vitamin Deficiency Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2028

    Figure 40: Europe Vitamin Deficiency Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2028

    Figure 41: Europe Vitamin Deficiency Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2028

    Figure 42: Europe Vitamin Deficiency Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2028

    Figure 43: Europe Vitamin Deficiency Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2028

    Figure 44: Europe Vitamin Deficiency Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2028

    Figure 45: Asia Pacific Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2028

    Figure 46: Asia Pacific Vitamin Deficiency Treatment Market Value Share, by Product Type, 2019 and 2028

    Figure 47: Asia Pacific Vitamin Deficiency Treatment Market Attractiveness Analysis, by Product Type, 2020–2028

    Figure 48: Asia Pacific Vitamin Deficiency Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2028

    Figure 49: Asia Pacific Vitamin Deficiency Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2028

    Figure 50: Asia Pacific Vitamin Deficiency Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2028

    Figure 51: Asia Pacific Vitamin Deficiency Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2028

    Figure 52: Asia Pacific Vitamin Deficiency Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2028

    Figure 53: Asia Pacific Vitamin Deficiency Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2028

    Figure 54: Latin America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2028

    Figure 55: Latin America Vitamin Deficiency Treatment Market Value Share, by Product Type, 2019 and 2028

    Figure 56: Latin America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Product Type, 2020–2028

    Figure 57: Latin America Vitamin Deficiency Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2028

    Figure 58: Latin America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2028

    Figure 59: Latin America Vitamin Deficiency Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2028

    Figure 60: Latin America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2028

    Figure 61: Latin America Vitamin Deficiency Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2028

    Figure 62: Latin America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2028

    Figure 63: Middle East & Africa Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2028

    Figure 64: Middle East & Africa Vitamin Deficiency Treatment Market Value Share, by Product Type, 2019 and 2028

    Figure 65: Middle East & Africa Vitamin Deficiency Treatment Market Attractiveness Analysis, by Product Type, 2020–2028

    Figure 66: Middle East & Africa Vitamin Deficiency Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2028

    Figure 67: Middle East & Africa Vitamin Deficiency Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2028

    Figure 68: Middle East & Africa Vitamin Deficiency Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2028

    Figure 69: Middle East & Africa Vitamin Deficiency Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2028

    Figure 70: Middle East & Africa Vitamin Deficiency Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2028

    Figure 71: Middle East & Africa Vitamin Deficiency Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2028

    Figure 72: GlaxoSmithKline plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 73: GlaxoSmithKline plc Breakdown of Net Sales (%), by Region, 2018

    Figure 75: GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2018

    Figure 76: Pfizer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

    Figure 78: Pfizer, Inc. Breakdown of Net Sales, by Region (%), 2018

    Figure 79: Merck & Co., Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 80: Merck & Co., Inc. Breakdown of Net Sales (%), by Region, 2018

    Figure 81: Merck & Co., Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 82: Merck & Co., Inc. Breakdown of Net Sales (%), by Business Segment, 2018

    Figure 83: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 84: Novartis AG Breakdown of Net Sales (%), by Country, 2018

    Figure 85: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 86: Novartis AG Breakdown of Net Sales (%), by Business Segment, 2018

    Figure 87: Cipla, Inc., Revenue (US$ Mn), 2015–2018

    Figure 88: Cipla, Inc., Breakdown of Net Sales (%), Therapy-wise, 2018

    Figure 90: Cipla, Inc., Breakdown of Net Sales (%), by Region, 2018

Copyright © Transparency Market Research, Inc. All Rights reserved